What is SegAna?
SegAna, LLC operates at the intersection of medical software and clinical oncology, specializing in near-real time treatment guidance systems. By facilitating enhanced clinical decision-making, the company addresses critical gaps in adaptive radiotherapy workflows. Furthermore, SegAna distinguishes itself through the manufacturing of patient-specific, deformable four-dimensional lung phantom simulators. These high-fidelity tools are essential for training medical professionals to establish precise treatment parameters, thereby improving outcomes for lung cancer patients. The company's dual-pronged approach of software innovation and hardware simulation positions it as a vital player in the evolving landscape of personalized radiation therapy.
How much funding has SegAna raised?
SegAna has raised a total of $100K across 1 funding round:
Debt
$100K
Debt (2021): $100K with participation from PPP
Key Investors in SegAna
PPP
Public-Private Partnership
What's next for SegAna?
With this late-stage funding, SegAna is poised to scale its operational footprint and deepen its market penetration. The strategic allocation of these resources will likely focus on the commercialization of its simulation technology and the expansion of its software suite to support broader clinical applications. As the healthcare industry shifts toward more data-driven, adaptive treatment models, SegAna's ability to provide actionable, real-time insights will be a key driver of its long-term growth. Investors and stakeholders will be monitoring the company's ability to integrate its phantom simulators into standard hospital workflows, which remains a critical milestone for achieving widespread adoption in the oncology market.
See full SegAna company page
